4 318

Cited 10 times in

Effective treatment of facial redness caused by atopic dermatitis using intense pulsed light systems

Authors
 SANG HO OH  ;  BYUNG KEE BAE  ;  TAE GYUN KIM  ;  YEON SOOK KWON  ;  JU HEE LEE  ;  KWANG HOON LEE 
Citation
 DERMATOLOGIC SURGERY, Vol.36(4) : 475-482, 2010 
Journal Title
 DERMATOLOGIC SURGERY 
ISSN
 1076-0512 
Issue Date
2010
MeSH
Adolescent ; Adult ; Cosmetic Techniques ; Dermatitis, Atopic/complications* ; Eczema/classification ; Eczema/etiology ; Eczema/therapy* ; Erythema/classification ; Erythema/etiology ; Erythema/therapy* ; Face ; Female ; Follow-Up Studies ; Humans ; Male ; Pain Measurement ; Patient Satisfaction ; Phototherapy* ; Quality of Life ; Treatment Outcome ; Young Adult
Abstract
BACKGROUND: Patients with facial atopic dermatitis (AD) experience psychological and social distress. OBJECTIVE: To evaluate the safety and the efficacy of intense pulsed light (IPL) treatment in patients with facial AD. MATERIALS AND METHODS: Eleven patients (9 men, 2 women; aged 14-39) with mild to moderate refractory facial AD were included in this study. In three separate sessions at 2-week intervals, the whole face was exposed to an IPL device using a 590-nm cut-off filter. Objective clinical response was examined using the Eczema Severity Score (ESS), a polarization color imaging system, and two dermatologists' evaluations. Data on quality of life were evaluated using the Dermatology Life Quality Index (DLQI). RESULTS: The ESS in 11 patients with facial AD was significantly lower 4 weeks after the third treatment (p=.005). Scaling (p=.003); edema, induration, and papules (p=.011); erythema (p=.009), and lichenification (p=.008) improved significantly. The erythema scale, examined using the polarization color imaging system, also decreased significantly (p=.04). No patients showed any noticeable side effects. Mean DLQI score improved significantly after the completion of therapy (from baseline to 4 weeks after the last IPL treatment; p=.005). CONCLUSION: IPL treatment could be used as an adjunct modality for the treatment of refractory facial AD with minimal side effects
Full Text
http://onlinelibrary.wiley.com/doi/10.1111/j.1524-4725.2010.01482.x/abstract
DOI
10.1111/j.1524-4725.2010.01482.x
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Dermatology (피부과학교실) > 1. Journal Papers
Yonsei Authors
Oh, Sang Ho(오상호) ORCID logo https://orcid.org/0000-0002-4477-1400
Lee, Kwang Hoon(이광훈)
Lee, Ju Hee(이주희) ORCID logo https://orcid.org/0000-0002-1739-5956
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/100876
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links